A study on preventive effect of cilostazol against deterioration of symptoms in acute stage of lacunar infarctions
Not Applicable
- Conditions
- ischemic stroke
- Registration Number
- JPRN-C000000454
- Lead Sponsor
- Department of Neurology,Iwate Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
patients with active bleeding or bleeding tendency chronic heart falure peptic ulcer anemia leukocytopenia thrombocytopenia liver dysfunction renal dysfunction neoplastic disorders allergy to aspirin or cilostazol asthma caused by aspirin patients taking antiplatelet drugs, anticoagulants or NSAIDS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Activity of Daily Living of 14days after onset which is assessed by modified Rankin Scale and Barthel Index
- Secondary Outcome Measures
Name Time Method IHSS: 7 and 14days after the admission JSS: 7 and 14days after the admission JSS-M: 7 and 14days after the admission Barthel Index: 7 and 14days after the admission